|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net (loss) | |||||
| Adjustments to reconcile net (loss) to net cash from operating activities: | |||||
| Depreciation | |||||
| Stock-based compensation | |||||
| Impairment loss on investment | |||||
| Bad debt | |||||
| Deferred income taxes | |||||
| Changes in assets and liabilities: | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable and accrued liabilities | |||||
| Other liabilities | |||||
| Accrued payroll and related expenses | |||||
| Accrued licensing costs | |||||
| Accounts receivable | |||||
| Prepaid income taxes | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of property and equipment | |||||
| Purchase of investments at cost | |||||
| Purchase of investments | |||||
| Proceeds from sale or maturity of investments | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Dividend | |||||
| Proceeds from exercise of options | |||||
| Withholding taxes paid on cashless exercise of restricted stock and restricted stock units | |||||
| Net cash used in financing activities | |||||
| Net (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Cash paid for income taxes | |||||
| Non-cash transaction | |||||
| ROU asset and lease liability | |||||
Loading...